A Molecular Pathologist’s Insight into Institutional Best Practices for NSCLC Biomarker Testing
March 7th 2023Dr Vail shares insight into his ideal institutional approach to biomarker testing for NSCLC, emphasizing the need for local molecular pathology expertise and available in-house biomarker panels.
Patient Case 1: A 71-year-old Woman with Newly Diagnosed mNSCLC
March 7th 2023Eric Vail, MD introduces a patient case, a 71-year-old Asian woman newly diagnosed with mNSCLC, followed by a focused discussion on how the panel would have approached biomarker testing and treatment initiation for the patient.
Clinical Experience with Coordinating Biomarker Testing for Patients with mNSCLC
February 28th 2023The panel discusses challenges that clinicians may experience when ordering biomarker testing for patients with mNSCLC, including insurance coverage barriers, timing of testing, insufficient biopsy samples, and inconclusive test results.